Cargando…
Radiolabeled Antibodies for Cancer Imaging and Therapy
SIMPLE SUMMARY: Monoclonal antibodies (mAbs) have the ability to specifically target tumor-cell antigens. This unique property has led to their use in the delivery of radioisotopes to tumor sites (scintigraphic imaging and radioimmunotherapy (RIT)). The choice of the radionuclide depends on its uniq...
Autores principales: | Parakh, Sagun, Lee, Sze Ting, Gan, Hui K., Scott, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946248/ https://www.ncbi.nlm.nih.gov/pubmed/35326605 http://dx.doi.org/10.3390/cancers14061454 |
Ejemplares similares
-
Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020) -
Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016) -
Antibody-drug conjugates: beyond current approvals and potential future strategies
por: Menon, Siddharth, et al.
Publicado: (2022) -
Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?
por: Parakh, Sagun, et al.
Publicado: (2021) -
Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer
por: Silva, Francisco, et al.
Publicado: (2020)